Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Halozyme Therapeutics, Inc. - Common Stock
(NQ:
HALO
)
71.20
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Halozyme Therapeutics, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
↗
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Earnings Outlook for Halozyme Therapeutics
↗
May 07, 2021
On Monday, May 10, Halozyme Therapeutics (NASDAQ:HALO) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per...
Via
Benzinga
Krystal Biotech Stock Sees Relative Strength Rating Jump To Noteworthy Territory
↗
April 29, 2021
When looking for the best stocks to buy and watch, focus on those with rising relative price strength. Krystal Biotech stock fits that bill.
Via
Investor's Business Daily
Biotech Cel-Sci Stock Joins Rank Of Stocks With RS Ratings Over 90
↗
April 28, 2021
Cel-Sci shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Biotech Applied Molecular Transport Stock Earns Relative Strength Rating Upgrade
↗
April 27, 2021
On Tuesday, Applied Molecular Transport stock reached an important technical milestone, seeing its Relative Strength Rating jump to 91 from 87.
Via
Investor's Business Daily
Arvinas Stock Clears Technical Benchmark With 80-Plus Relative Strength Rating
↗
April 22, 2021
Arvinas shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 79 to 84.
Via
Investor's Business Daily
Scholar Rock Stock Shows Market Leadership With Healthy Jump To 83 RS Rating
↗
April 21, 2021
When looking for the best stocks to buy and watch, focus on those with rising relative price strength. Scholar Rock stock fits that bill.
Via
Investor's Business Daily
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.